Predicting the next round of drugs for Medicare price negotiation.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 39630882.
- Also identified by DOI 10.1126/scitranslmed.adq5711.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
There is uncertainty regarding which brand-name prescription drugs will have their prices negotiated by Medicare in 2025. This Viewpoint analyzes the process that will be used to select the next 15 drugs for price negotiation.
Medical subject headings
- Drug Costs
- Medicare
- Negotiating